Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012
The overall purpose of these guidelines is to provide guidance on best clinical practice in the treatment and management of adults with HIV infection with antiretroviral therapy (ART). The scope… Expand
Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
BACKGROUND Sub-optimal adherence to highly active antiretroviral therapy (HAART) among injection drug users (IDUs) is a significant concern. As such, there is an urgent need to identify psychosocial… Expand
British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2015
Writing Group Duncan Churchill, Chair, Royal Sussex County Hospital, Brighton, UK Laura Waters, Vice Chair, Mortimer Market Centre, London, UK Nadia Ahmed, Mortimer Market Centre, London, UK Brian… Expand
British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.)
SELF-SELECTED AND RANDOMLY SELECTED RESPONDENTS IN A COMPUTER NETWORK SURVEY
A computer survey collects data directly from respondents. Usually respondents type responses on a personal computer (Synodinos and Brennan 1988), but networks permit remote data collection and this… Expand
The effects of a nucleoside-sparing antiretroviral regimen on the pharmacokinetics of ritonavir-boosted darunavir in HIV type-1-infected patients.
BACKGROUND Nucleoside-sparing combination antiretroviral therapy (cART) regimens might be an attractive therapeutic option for HIV type-1 (HIV-1)-infected patients; however, the pharmacokinetic… Expand
Time Is Short and the Water Rises, Operation Gwamba: The Story of the Rescue of 10,000 Animals from Certain Death in a South American Rain Forest
Cost-Effectiveness of Early Treatment with First-Line NNRTI-Based HAART Regimens in the UK, 1996-2006
Aim Calculate time to first-line treatment failure, annual cost and cost-effectiveness of NNRTI versus PIboosted first-line HAART regimens in the UK, 1996–2006. Background Population costs for HIV… Expand